Wills Financial Group’s AbbVie ABBV Stock Holding History

Wills Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,283	Closed	-$456K	–	70
2017 Q2	$456K	Sell	6,283 -633	-9%	-$42.6K	0.34%	53
2017 Q1	$451K	Sell	6,916 -460	-6%	-$28.9K	0.35%	50
2016 Q4	$462K	Buy	7,376 +12	+0.2%	+$732	0.38%	51
2016 Q3	$464K	Buy	7,364 +744	+11%	+$48.2K	0.41%	50
2016 Q2	$410K	Sell	6,620 -296	-4%	-$18K	0.34%	54
2016 Q1	$395K	Buy	6,916 +41	+0.6%	+$2.29K	0.34%	55
2015 Q4	$407K	Buy	6,875 +13	+0.2%	+$749	0.36%	56
2015 Q3	$373K	Buy	6,862 +11	+0.2%	+$716	0.34%	56
2015 Q2	$460K	Buy	6,851 +2,358	+52%	+$154K	0.39%	53
2015 Q1	$263K	Hold	4,493	–	–	0.22%	68
2014 Q4	$294K	Hold	4,493	–	–	0.24%	66
2014 Q3	$259K	Hold	4,493	–	–	0.22%	68
2014 Q2	$254K	Buy	4,493 +595	+15%	+$31.2K	0.21%	71
2014 Q1	$200K	Hold	3,898	–	–	0.19%	68
2013 Q4	$205K	Buy	+3,898	New	+$192K	0.21%	65

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wills Financial Group's ABBV Position: Q3 2017 in Review

Wills Financial Group sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 6,283 shares — an estimated $456K sold.

Wills Financial Group first reported a position in ABBV in Q4 2013 and held it in 15 quarters. The position peaked at $464K in Q3 2016. 1,798 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

Wills Financial Group reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
Wills Financial Group sold 6,283 AbbVie shares in Q3 2017, an estimated $456K.
Wills Financial Group first reported a position in AbbVie in Q4 2013 and held it in 15 quarters.
Wills Financial Group's AbbVie position peaked at $464K in Q3 2016.
1,798 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Wills Financial Group's 13F filing for Q3 2017, filed 14 Nov 2017.